22,157,014 ordinary shares of the company TiGenix were admitted on the regulated market Eurolist by Euronext Brussels. The IPO consisted of a total offering of 9.2 million shares, raising a total of EUR 46 million. Subscriptions to the offer were closed early as the placement was oversubscribed 4.5 times.
At the opening price of EUR 5.89, 17.80% above the reference price of EUR 5, the company's market capitalization totals EUR 130.5 million.
TiGenix is a late-stage biomedical company and operates at the cutting edge of regenerative medicine and focuses on the development of innovative local treatments for damaged and osteoarthritic joints.
TiGenix is traded on the NSC platform under the following codes:
Euronext Brussels: Stock Code: TIG
ISIN Code: BE0003864817
SVM Code: 3864.81 -- www.euronext.com
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
